Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/23 16:48 | 8/10/23 | ACGN | Health | BioPrd | Biological Products, (No Diag | Gowen Maxine | PA | D | S | 0 | 0.5100 | 0 | 0 | -100 | 0 | I | |||||||||||||||
8/11/23 16:30 | 8/10/23 | ACGN | Health | BioPrd | Biological Products, (No Diag | Milano Vincent | PA | D | S | -2 | 0.5331 | 0 | -3 | -27 | 9 | D | |||||||||||||||
7/19/23 16:05 | 7/12/23 | ACGN | Health | BioPrd | Biological Products, (No Diag | Pillar Invest Corp | E9 | T | S.m | -9 | 1.56 | 0 | -6 | -1 | 657 | I | |||||||||||||||
5/18/23 14:38 | 5/15/23 | ACGN | Health | BioPrd | Biological Products, (No Diag | Chopra Atul | OH | T | S.m | -195 | 1.44 | 0 | -136 | -10 | 1,205 | I | |||||||||||||||
5/18/23 14:35 | 5/12/23 | ACGN | Health | BioPrd | Biological Products, (No Diag | Chopra Atul | OH | T | S | -127 | 1.56 | 0 | -81 | -6 | 1,341 | I | |||||||||||||||
5/18/23 14:34 | 5/11/23 | ACGN | Health | BioPrd | Biological Products, (No Diag | Chopra Atul | OH | T | S | -87 | 1.84 | 0 | -47 | -3 | 1,422 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |